Inhaled nitric oxide for the adjunctive therapy of severe malaria: Protocol for a randomized controlled trial

BACKGROUND: Severe malaria remains a major cause of global morbidity and mortality. Despite the use of potent anti-parasitic agents, the mortality rate in severe malaria remains high. Adjunctive therapies that target the underlying pathophysiology of severe malaria may further reduce morbidity and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawkes, Michael, Opoka, Robert O, Namasopo, Sophie, Miller, Christopher, Thorpe, Kevin E, Lavery, James V, Conroy, Andrea L, Liles, W Conrad, John, Chandy C, Kain, Kevin C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151218/
https://www.ncbi.nlm.nih.gov/pubmed/21752262
http://dx.doi.org/10.1186/1745-6215-12-176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151218/
https://www.ncbi.nlm.nih.gov/pubmed/21752262
http://dx.doi.org/10.1186/1745-6215-12-176

Ejemplares similares